Literature DB >> 7696306

Refolding of alpha 1-antitrypsin expressed as inclusion bodies in Escherichia coli: characterization of aggregation.

K S Kwon1, S Lee, M H Yu.   

Abstract

Recombinant alpha 1-antitrypsin (alpha 1AT) produced as inclusion bodies in Escherichia coli was purified via several steps including solubilization of the inclusion bodies in 8 M urea and refolding by direct dilution of denaturant, followed by ion-exchange chromatography. The purified recombinant alpha 1AT has an activity comparable to human plasma alpha 1AT. During refolding, prolonged incubation of the alpha 1AT polypeptides at intermediate urea concentration favored production of inactive but soluble aggregates, which could regain activity after denaturation and renaturation. Nondenaturing polyacrylamide gel electrophoresis of the aggregates revealed the existence of dimers and higher oligomers. Immunological approach to characterize conformation showed that the oligomers were distinct from the native, the cleaved, or the denatured form, but was similar to the polymers induced from the native structure in mild denaturing condition. These results suggest that the oligomers are formed through specific interactions between aggregation-competent species which are stabilized at intermediate denaturant concentration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7696306     DOI: 10.1016/0167-4838(94)00224-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition.

Authors:  M Simonovic; K Volz
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

2.  Specificity and reactive loop length requirements for crmA inhibition of serine proteases.

Authors:  Lisa D Tesch; Manikanahally P Raghavendra; Tina Bedsted-Faarvang; Peter G W Gettins; Steven T Olson
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

3.  Short-lived protease serpin complexes: partial disruption of the rat trypsin active site.

Authors:  Lu Liu; Nicole Mushero; Lizbeth Hedstrom; Anne Gershenson
Journal:  Protein Sci       Date:  2007-11       Impact factor: 6.725

Review 4.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

5.  Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of α1PDX (α1-protease inhibitor Portland)-serpin B8 and furin active-site loop chimeras.

Authors:  Gonzalo Izaguirre; Lixin Qi; Mary Lima; Steven T Olson
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

6.  Expression and Purification of Active Recombinant Human Alpha-1 Antitrypsin (AAT) from Escherichia coli.

Authors:  Beena Krishnan; Lizbeth Hedstrom; Daniel N Hebert; Lila M Gierasch; Anne Gershenson
Journal:  Methods Mol Biol       Date:  2017

7.  Probing the local conformational change of alpha1-antitrypsin.

Authors:  Je-Hyun Baek; Hana Im; Un-Beom Kang; Ki Moon Seong; Cheolju Lee; Joon Kim; Myeong-Hee Yu
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

8.  Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.

Authors:  Gonzalo Izaguirre; Alireza R Rezaie; Steven T Olson
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

9.  Expression of modified gene encoding functional human alpha-1-antitrypsin protein in transgenic tomato plants.

Authors:  Saurabh Agarwal; Rahul Singh; Indraneel Sanyal; D V Amla
Journal:  Transgenic Res       Date:  2008-03-05       Impact factor: 2.788

10.  Smoothing a rugged protein folding landscape by sequence-based redesign.

Authors:  Benjamin T Porebski; Shani Keleher; Jeffrey J Hollins; Adrian A Nickson; Emilia M Marijanovic; Natalie A Borg; Mauricio G S Costa; Mary A Pearce; Weiwen Dai; Liguang Zhu; James A Irving; David E Hoke; Itamar Kass; James C Whisstock; Stephen P Bottomley; Geoffrey I Webb; Sheena McGowan; Ashley M Buckle
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.